BIOMARIN PHARMACEUTICAL INC: Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in BIOMARIN PHARMACEUTICAL INC. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
4
13F filers
Aggregate Value
$189.1M
Across holders
Last Price
—
EOD close
Sector
—
GICS
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| OAKTREE CAPITAL MANAGEMENT LP CIK 0000949509 | Hedge Fund | 64.03M | $62.4M | 33.0% | 0.9% | Added | +$7.8M | Q2 2026 |
| CAPSTONE INVESTMENT ADVISORS, LLC CIK 0001426196 | Hedge Fund | 62.43M | $60.8M | 32.2% | 0.1% | Added | +$8.0M | Q2 2026 |
| Man Group plc CIK 0001637460 | Hedge Fund | 48.78M | $47.6M | 25.2% | 0.1% | Unchanged | $-41.8M | Q2 2026 |
| Verition Fund Management LLC CIK 0001454027 | Hedge Fund | 18.80M | $18.3M | 9.7% | 0.1% | Added | +$9.7M | Q2 2026 |
Added
Hedge Fund
$62.4M· 33.0% of total· 0.9% port· 64.03M sh· +$7.8M QoQ· Q2 2026
Added
Hedge Fund
$60.8M· 32.2% of total· 0.1% port· 62.43M sh· +$8.0M QoQ· Q2 2026
Unchanged
Hedge Fund
$47.6M· 25.2% of total· 0.1% port· 48.78M sh· $-41.8M QoQ· Q2 2026
Added
Hedge Fund
$18.3M· 9.7% of total· 0.1% port· 18.80M sh· +$9.7M QoQ· Q2 2026